The University of Southampton
University of Southampton Institutional Repository

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.
Addition of CMLVAX100 to conventional treatment in patients with chronic myeloid leukaemia might favour further reduction of residual disease and increase the number of patients reaching a molecular response.
0140-6736
657-662
Bocchia, M.
469a1dc3-f5f8-4aa9-8837-6906eb0a23b3
Gentili, S.
d6ea9f67-f209-4012-abff-dc2677f47d3d
Abruzzese, E.
39821d71-5106-4c09-8d55-b58fe5e6f71a
Fanelli, A.
f9c3599a-e0c3-4eac-9db6-a9e548ded133
Iuliano, F.
b1b52c19-83cd-4b4c-8fde-08dc2ec8e6a8
Tabilio, A.
13fbae62-64dd-4793-b755-022bd408e793
Amabile, M.
9443e54a-e305-455a-bfea-3cab90d6f157
Forconi, F.
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Gozzetti, A.
2dd19886-f8ce-422b-afba-23a8ab0423d5
Raspadori, D.
bf030b4a-d671-41d0-bd9f-fac632ed88c8
Amadori, S.
36da3dc5-7c43-4e5f-bbd5-d6d944c37a92
Lauria, F.
735fa868-573e-4a9b-b409-a3316d397c4a
Bocchia, M.
469a1dc3-f5f8-4aa9-8837-6906eb0a23b3
Gentili, S.
d6ea9f67-f209-4012-abff-dc2677f47d3d
Abruzzese, E.
39821d71-5106-4c09-8d55-b58fe5e6f71a
Fanelli, A.
f9c3599a-e0c3-4eac-9db6-a9e548ded133
Iuliano, F.
b1b52c19-83cd-4b4c-8fde-08dc2ec8e6a8
Tabilio, A.
13fbae62-64dd-4793-b755-022bd408e793
Amabile, M.
9443e54a-e305-455a-bfea-3cab90d6f157
Forconi, F.
ce9ed873-58cf-4876-bf3a-9ba1d163edc8
Gozzetti, A.
2dd19886-f8ce-422b-afba-23a8ab0423d5
Raspadori, D.
bf030b4a-d671-41d0-bd9f-fac632ed88c8
Amadori, S.
36da3dc5-7c43-4e5f-bbd5-d6d944c37a92
Lauria, F.
735fa868-573e-4a9b-b409-a3316d397c4a

Bocchia, M., Gentili, S., Abruzzese, E., Fanelli, A., Iuliano, F., Tabilio, A., Amabile, M., Forconi, F., Gozzetti, A., Raspadori, D., Amadori, S. and Lauria, F. (2005) Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial. The Lancet, 365 (9460), 657-662. (doi:10.1016/S0140-6736(05)17945-8). (PMID:15721470)

Record type: Article

Abstract

Addition of CMLVAX100 to conventional treatment in patients with chronic myeloid leukaemia might favour further reduction of residual disease and increase the number of patients reaching a molecular response.

Full text not available from this repository.

More information

Published date: February 2005
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 358172
URI: http://eprints.soton.ac.uk/id/eprint/358172
ISSN: 0140-6736
PURE UUID: 2b751290-97fd-4d07-a6ff-7ec5fda5721b

Catalogue record

Date deposited: 14 Nov 2013 13:54
Last modified: 05 Oct 2018 12:10

Export record

Altmetrics

Contributors

Author: M. Bocchia
Author: S. Gentili
Author: E. Abruzzese
Author: A. Fanelli
Author: F. Iuliano
Author: A. Tabilio
Author: M. Amabile
Author: F. Forconi
Author: A. Gozzetti
Author: D. Raspadori
Author: S. Amadori
Author: F. Lauria

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×